Association of clinical biomarker-based biological age and aging trajectory with cardiovascular disease and all-cause mortality in Chinese adults: a population-based cohort study
Open Access
- 4 March 2025
- journal article
- research article
- Published by Springer Nature in BMC Public Health
- Vol. 25 (1) , 1-15
Abstract
Background: Evidence on the association of clinical biomarker-based biological age (BA) with cardiovascular disease (CVD) and mortality remains insufficient, particularly concerning aging trajectories' relationship with these two outcomes. Methods: Seventy-five thousand five hundred thirty-seven Chinese adults from the Kailuan study who participated in the first checkup (2006–2007) were included. BA was predicted by 32 clinical indicators using deep neural networks models. Aging status was divided into decelerated, accelerated, and normal aging based on BA in the first checkup. Six aging trajectories were developed in the initial three checkups. CVD and mortality were followed up till December 31, 2021. Results: After adjusting for chronological age, sex, education level, occupation, physical activity, smoking status, alcohol consumption, salt consumption habit, history of hypertension, diabetes, and dyslipidemia, as well as the use of antihypertensive, antidiabetic, and lipid-lowering drugs, Cox proportional hazard models showed that relative to normal aging, accelerated aging was a risk factor for CVD (adjusted hazard ratio [aHR], 1.17 [95% CI 1.11–1.23]) and mortality (aHR, 1.17 [1.12–1.22]), while participants with decelerated aging had a lower risk for CVD (aHR, 0.85 [0.80–0.90]) and mortality (aHR, 0.86 [0.82–0.90]). Relative to low-stable trajectory, other aging trajectories associated with higher risk of CVD and death, and high-stable trajectory associated with the highest risk of CVD (aHR, 1.62 [1.45–1.81]) and mortality (aHR, 1.55 [1.41–1.71]). Relative to high-stable trajectory, high-decreasing trajectory was associated with lower risk of CVD (aHR, 0.76 [0.67–0.86]) and death (aHR, 0.78 [0.70–0.87]), and decreasing-increasing trajectory was associated with lower risk of death (aHR, 0.86 [0.75–0.98]). Conclusions: Accelerated BA aging is associated with a higher risk of CVD and mortality, whereas decelerated aging is associated with a lower risk compared to normal aging. Those persistently at high aging levels are at the highest risk for both CVD and death; conversely, it is the act of lowering and continually maintaining a reduced aging state that effectively mitigates these risks.Keywords
Funding Information
- National Human Genetic Resources Sharing Service Platform, Ministry of Science and Technology, People’s Republic of China (2005DKA21300)
- National Key Research and Development Program, Ministry of Science and Technology, People’s Republic of China (2016YFC1000307)
This publication has 44 references indexed in Scilit:
- Associations of healthy aging index and all-cause and cause-specific mortality: a prospective cohort study of UK Biobank participantsGeroScience, 2023
- Biomarkers of agingScience China Life Sciences, 2023
- Modeling biological age using blood biomarkers and physical measurements in Chinese adultsEBioMedicine, 2023
- Associations between frailty trajectories and frailty status and adverse outcomes in community‐dwelling older adultsJournal of Cachexia, Sarcopenia and Muscle, 2021
- Global Burden of Cardiovascular Diseases and Risk Factors, 1990–2019JACC, 2020
- A research agenda for ageing in China in the 21st century (2nd edition): Focusing on basic and translational research, long-term care, policy and social networksAgeing Research Reviews, 2020
- The World Health Organization (WHO) approach to healthy ageingMaturitas, 2020
- Fourth Universal Definition of Myocardial Infarction (2018)JACC, 2018
- Model construction for biological age based on a cross-sectional study of a healthy Chinese han populationThe Journal of nutrition, health and aging, 2017
- Effects of biological age on the associations of blood pressure with cardiovascular and non-cardiovascular mortality in old age: A population-based studyInternational Journal of Cardiology, 2016